[artículo] 
inJournal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 4 (Agosto) . - pp. 410-416

Título :	Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics
Tipo de documento:	texto impreso
Autores:	Ilya Reznik, Autor ; Pinkhas Sirota, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 410-416
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Comportamiento compulsivo, Fluvoxamina, Haloperidol, Comportamiento obsesivo, Esquizofrenia.
Resumen:	Obsessive-compulsive-related disorders are frequently comorbid with schizophrenia. The existence of obsessive and compulsive symptoms in patients with schizophrenia represents one of the most severe types of psychotic disorders and may predict a poor prognosis in most cases. Previous pilot studies and case reports have shown that the condition of some patients with schizophrenia did not exacerbate and even improved when serotonin reuptake inhibitors (SSRIs) were added to their standard neuroleptic regimen.
Link:	./index.php?lvl=notice_display&id=31176

[artículo] Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics [texto impreso] / Ilya Reznik, Autor ; Pinkhas Sirota, Autor . - 2023 . - pp. 410-416.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 4 (Agosto) . - pp. 410-416

Palabras clave:	Antipsicóticos, Comportamiento compulsivo, Fluvoxamina, Haloperidol, Comportamiento obsesivo, Esquizofrenia.
Resumen:	Obsessive-compulsive-related disorders are frequently comorbid with schizophrenia. The existence of obsessive and compulsive symptoms in patients with schizophrenia represents one of the most severe types of psychotic disorders and may predict a poor prognosis in most cases. Previous pilot studies and case reports have shown that the condition of some patients with schizophrenia did not exacerbate and even improved when serotonin reuptake inhibitors (SSRIs) were added to their standard neuroleptic regimen.
Link:	./index.php?lvl=notice_display&id=31176